Search results
18 mar 2013 · Catheter ablation of atrial fibrillation (AF) has become an established therapeutic modality for the treatment of patients with symptomatic AF. 1 To date, studies reporting outcomes of AF ablation have predominantly limited follow‐up to 1 to 2 years after the index ablation procedure. 2, 3, 4 Although the long‐term efficacy of AF ablation ...
31 sty 2023 · To the best of our knowledge, this is the first meta-analysis that reported the dose-response association between weight loss and the risk of AF recurrence after ablation, providing an informative finding for the improvement of outcomes of AF ablation.
Weight loss has be shown to be beneficial for cardiovascular health by directly reducing the risk of AF and incidence of other cardiovascular events [5]. This review delves into the intricate relationship between obesity and AF, emphasizing the beneficial impact of weight loss on AF.
15 paź 2019 · Morbid obesity is associated with unacceptable high recurrence rates following atrial fibrillation ablation. The role of risk-factor modification including weight loss and improved glycemic control in reducing arrhythmia recurrence following ablation has been highlighted in recent years.
18 maj 2022 · Abstract. Objectives: This study aims to determine the relationship between weight loss and outcomes in patients with atrial fibrillation (AF) ablation, as well as the potential...
26 lip 2023 · Obesity is a well-known risk factor for atrial fibrillation (AF). We aim to evaluate the effect of baseline obesity on procedural complications, AF recurrence, and symptoms following catheter ablation (CA).
31 sty 2023 · Patients in diet group experienced a mean weight loss of 8.2 (±7.1) kgs prior to AF ablation (P < .01 for comparison to baseline and control group). About 14 (28%) patients in the diet group...
